NCT01315574 - Effects of Anti-Glaucoma Medications on the Ocular Surface | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Glaucoma

Interventions

DRUG

Travoprost

One drop Travatan Z (0.004% ophthalmic solution) in affected eye once daily.

DRUG

Latanoprost

One drop Xalatan (0.005% ophthalmic solution) in affected eye once daily.

Trial Locations (1)

Massachusetts Eye and Ear Infirmary, Boston